“NOW's facility and testing are independently verifiable”
NOW manufactures in a UL GMP-certified, NPA A-rated facility and publishes QC and third-party testing detail — among the most auditable of the large mass-market supplement brands.

Great brand and value, slightly too much per cap
NOW Foods is the workhorse pick: ~$16 for 60 veg caps standardized to a minimum 3% rosavins / 1% salidroside, made in a UL GMP-certified, NPA A-rated facility with in-house and third-party testing you can verify. The single knock is dosing — 500 mg in one capsule sits above the 200-400 mg range the trials favored, with no easy way to take less without splitting.
Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Standardized to minimum 3% total rosavins and minimum 1% salidroside — the correct studied ratio. Slightly behind the specialist brands only because it's a 'minimum' spec rather than a targeted percentage.
500 mg per cap is above the 200-400 mg trial window. Fine if you tolerate the high end, but there's no clean way to take 250 mg short of opening the capsule.
UL GMP-certified, NPA A-rated facility with both in-house and outside lab testing. NOW publishes extensive QC documentation — one of the more transparent large brands.
A standard veg capsule of root extract — one cap covers a full day, but there's no clean way to take 250 mg short of opening the capsule.
~$16 for 60 full-dose caps is strong value, and one cap covers a full day. Nutricost edges it slightly on raw price, but NOW's verifiable QC justifies the small premium.
“NOW's facility and testing are independently verifiable”
NOW manufactures in a UL GMP-certified, NPA A-rated facility and publishes QC and third-party testing detail — among the most auditable of the large mass-market supplement brands.
“500 mg is the optimal rhodiola dose”
500 mg is effective and within the broad range studied, but the classic fatigue trials centered on 200-400 mg; 500 mg overshoots the low-to-mid window rather than matching it (Olsson 2009, PMID 19016404).
Unlike several value labels here, NOW's certifications (UL GMP, NPA A-rating) are verifiable and its QC is documented. For a category where actives are the whole ballgame, that auditability is worth a lot.
The 500 mg single cap is convenient, but it removes the ability to dose low. If you want to start at 200-250 mg, Life Extension or Thorne give you that control; NOW does not without splitting.
For a set-and-forget, one-cap-a-day rhodiola from a brand you can audit, NOW is an easy recommendation. Dose-cautious users or anyone wanting to titrate should step to Life Extension (250 mg) or Thorne (100 mg) instead.
Same ratio at a dose that actually matches the trials, and even cheaper — the better pick if 500 mg feels like too much.
See it on the list →A few dollars cheaper for the same dose and ratio if you want the absolute lowest price and can accept thinner sourcing transparency.
See it on the list →Found some positive but inconsistent evidence for rhodiola in fatigue; trials were small and heterogeneous, warranting cautious interpretation.
576 mg/day SHR-5 improved stress-related fatigue vs placebo, supporting the low-hundreds mg dose range.